← Leaderboards
Karl Gorzelnik
Lynntech, Inc.
$761,274
Attributed
$902,926
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $329.4K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$902,926 · 4
By mechanism
R43$902,926 · 4
Top collaborators
- Mark Lee Harlow1 shared
Most similar at Lynntech, Inc.
Same institution · by research overlap
- Season S-S Wong$5,414,920
- John E Mueller$3,591,378
- Mark Lee Harlow$1,041,641
Others in their field
Other Emerging Leaders on “Specificity”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$225,117,487
- Kevin Urdahl · Seattle Children'S Hospital$79,298,344
- Yunda Huang · Fred Hutchinson Cancer Center$71,543,089
Research focus
SpecificityDetectionPoint Of CareVirusReplicaseDiagnostic AssayMediatingNucleic AcidsSamplingViral RnaSignal TransductionRna AmplificationDevicesDiagnosticIn SituInfectionLaboratoriesBenchmarkingGenomeGuide RnaLateral Flow AssayEnzymesBaseBacterial Rna
Grant awards (4)
Make an OFERR: Optimization for Enhanced RNA Replication$283,304
R43 · FY2024 · GM · contact PI
An Isothermal Method to Amplify RNA from Bloodborne Viruses$290,196
R43 · FY2023 · AI · contact PI
Point-of-care diagnostic for amplification and detection of SARS-CoV-2 RNA$260,571
R43 · FY2021 · AI · contact PI
Development of a Simple Diagnostic for Causative Agents of Schistosomiasis$68,855
R43 · FY2021 · AI · contact PI